Format

Send to

Choose Destination
Transfus Med Rev. 2001 Jul;15(3):213-23.

Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.

Author information

1
University of Iowa College of Medicine, Iowa City, Iowa 52242-1182, USA.

Abstract

Transfusion-dependent anemia remains a problem for preterm infants, particularly those with a birth weight less than 1.0 kg. Several studies have documented the efficacy and safety of transfusing red blood cells stored up to 42 days as a means to diminish donor exposures. Recombinant erythropoietin therapy has not been widely adopted because it does not consistently reduce the need for red blood cell transfusions in very low-birth weight preterm infants.

PMID:
11471123
DOI:
10.1053/tmrv.2001.24592
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center